Compare Dolby Laboratories, Inc. (DLB) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs DexCom, Inc. — how do they compare? Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 5.9× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DLB | DXCM | |
|---|---|---|
Market Cap | $5.75B | $33.79B |
Sector | Industrials | Health |
52-Week High | $75.62 | $89.53 |
52-Week Low | $48.51 | $54.84 |
Enterprise Value | $5.12B | $33.24B |
Dividend Yield | 2.35% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
